13.12.2016 12:36:49
|
Lilly Announces Program To Provide Insulin At Discounted Prices Starting Jan. 1
(RTTNews) - Eli Lilly and Co. (LLY) said that people who use Lilly insulin will be able to access discounted prices for their purchases starting January 1, 2017 via mobile and web platforms hosted by Blink Health.
The discounts, provided by Lilly through a partnership with Express Scripts (ESRX), may reduce costs for people who pay full retail prices at the pharmacy, such as those who have no insurance or are in the deductible phase of their high-deductible insurance plans.
Lilly noted that the starting point of the offer will coincide with the new deductible period for many health plans on January 1, 2017. The program includes all presentations of Humalog (insulin lispro injection 100 units/mL) available at pharmacies, all Humulin U100 formulations (insulin human injection 100 units/mL), and BASAGLAR (insulin glargine injection 100 units/mL), a long-acting follow-on biologic being introduced this month by Lilly and Boehringer Ingelheim.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Eli Lillymehr Nachrichten
Analysen zu Eli Lillymehr Analysen
20.12.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
31.10.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
13.02.24 | Eli Lilly Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
Eli Lilly | 859,30 | 0,16% |
|